Ads
related to: pfizer vaccine- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Questions About Cost?
Visit To Find More Information
On COVID-19 Vaccination Costs.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Pneumococcal Pneumonia
Visit VaxAssist.com To
See If You Are Eligible.
- Schedule A Vaccine
Search results
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 6 hours agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 5 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 16 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 6 hours agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 16 hours agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 hours agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 11 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...